FRANKLIN LAKES, N.J. , June 1, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor conferences: Goldman Sachs 41 st Annual Global Healthcare Conference Webcast June

FRANKLIN LAKES, N.J. (June 1, 2020) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy

FRANKLIN LAKES, N.J. , May 26, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 , at 11:00 a.m. ET .

FRANKLIN LAKES, N.J. , May 21, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it has priced its previously announced registered offerings of $1.5 billion of common stock, par value $1.00 per share, at a public offering price of $240.00 per share, and $1.5

FRANKLIN LAKES, N.J. , May 19, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it has commenced registered offerings of $1.5 billion of common stock, par value $1.00 per share, and $1.5 billion of depositary shares, each representing a 1/20th interest in

- As reported, revenues of $4.253 billion increased 1.4 percent - On a currency-neutral basis, revenues increased 2.4 percent - As reported, diluted earnings per share of $0.53 increased 857.1 percent, primarily due to charges recorded in the prior year - As adjusted, diluted earnings per share of